MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
// Xiaoyuan He 1, * , Aimin Yang 1, * , Daniel G. McDonald 2 , Ellen C. Riemer 1 , Kenneth N. Vanek 2 , Bradley A. Schulte 1 and Gavin Y. Wang 1, 3 1 Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA 2 Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA 3 Cancer Genes and Molecular Regulation Program of Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA * These authors have contributed equally to this work Correspondence to: Gavin Y. Wang, email: wangy@musc.edu Keywords: microRNA-34a (miR-34a), ionizing radiation, non-small cell lung cancer, cellular senescence, c-Myc Received: February 28, 2017 Accepted: June 09, 2017 Published: July 15, 2017 ABSTRACT MicroRNAs (miRNAs) are a new class of gene expression regulators that have been implicated in tumorigenesis and modulation of the responses to cancer treatment including that of human non-small cell lung cancer (NSCLC). However, the role of miR-34a in ionizing radiation (IR)-induced senescence in NSCLC cells remains poorly understood. Here we report that IR-induced premature senescence correlates with upregulation of miR-34a expression in NSCLC cells. Ectopic overexpression of miR-34a by transfection with synthetic miR-34a mimics markedly enhances IR-induced senescence, whereas inhibition of miR-34a by transfection with a synthetic miR-34a inhibitor attenuates IR-induced senescence. Clonogenic assays reveal that treatment with miR-34a mimics augments IR-induced cell killing in human NSCLC cells. Mechanistically, we found that the senescence-promoting effect of miR-34a is associated with a dramatic down-regulation of c-Myc (Myc) expression, suggesting that miR-34a may promote IR-induced senescence via targeting Myc. In agreement with this suggestion, knockdown of Myc expression by RNAi recapitulates the senescence-promoting effect of miR-34a and enhances IR-induced cell killing in NSCLC cells. Collectively, these results demonstrate a previously unrecognized role for miR-34a in modulating IR-induced senescence in human NSCLC cells and suggest that pharmacological intervention of miR-34a expression may represent a new therapeutic strategy for improving the efficacy of lung cancer radiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Therapy-induced senescence in cancer.
Ewald, J. A., Desotelle, J. A., Wilding, G., & Jarrard, D. F. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq364 · Cited by 824 · cited 6×
“…been shown that therapy-induced senescence can be achieved using much lower doses of chemotherapy than those required to induce apoptosis, suggesting that high doses of anticancer agent may lead to apoptosis whereas low level treatments primarily induce premature senescence in cancer cells [5, 6].”
InfluentialT-helper-1-cell cytokines drive cancer into senescence
Braumüller, H., Wieder, T., Brenner, E., Aßmann, S., Hahn, M., Alkhaled, M., Schilbach, K., Essmann, F., Kneilling, M., Griessinger, C., et al. (2013) · Nature · doi:10.1038/nature11824 · Cited by 720
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., et al. (2013) · Nature · doi:10.1038/nature12437 · Cited by 541 · cited 1×
“Cellular senescence is a state of permanent cell cycle arrest that can be triggered by continuous passage of cells in culture, oxidative stress, treatment with chemotherapeutic agents or radiation and activation of oncogenes such as Ras [5–11 , 27– 29].”
Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
Rader, J., Russell, M. R., Hart, L. S., Nakazawa, M. S., Belcastro, L. T., Martinez, D., Li, Y., Carpenter, E. L., Attiyeh, E. F., Diskin, S. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1675 · Cited by 394 · cited 2×
“Cellular senescence is a state of permanent cell cycle arrest that can be triggered by continuous passage of cells in culture, oxidative stress, treatment with chemotherapeutic agents or radiation and activation of oncogenes such as Ras [5–11 , 27– 29].”
Total body irradiation selectively induces murine hematopoietic stem cell senescence.
Wang, Y., Schulte, B. A., LaRue, A. C., Ogawa, M., & Zhou, D. (2006) · Blood · doi:10.1182/blood-2005-04-1418 · Cited by 351
Self-citationMolecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012602599 · Cited by 312
Cellular senescence in vivo: a barrier to tumorigenesis
Prieur, A., & Peeper, D. S. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.007 · Cited by 260 · cited 1×
“Induction of senescence is an important mechanism of tumor prevention in response to oncogene activation [43, 44].”
Cited by
Hu, Y., Xia, W., & Hou, M. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3838 · Cited by 38
Tong, N., Jin, R., Zhou, Z., & Wu, X. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00137 · Cited by 26
Velalopoulou, A., Chatterjee, S., Pietrofesa, R., Koziol-White, C., Panettieri, R., Lin, L., Tuttle, S., Berman, A., Koumenis, C., & Christofidou-Solomidou, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122525 · Cited by 22
“Specifically, modulating radiation-induced senescence of non-small cell lung cancer cells has been investigated as a mechanism of overcoming radioresistance [23,24].”
Background
Metadata
- Authors
- He, X., Yang, A., McDonald, D. G., Riemer, E. C., Vanek, K. N., Schulte, B. A., & Wang, G. Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-07-15
- Volume
- 8
- Issue
- 41
- Pages
- 69797-69807
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2735491497
- Cited by
- 64
- References
- 10
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.